Purpose: To test if a RapidPlan DVH estimation model and its training plans can be improved interactively through a closed-loop evolution process.
| INTRODUCTION
Knowledge-based radiotherapy treatment planning is deemed to reduce the inter-planner varieties of plan quality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and expedite the planning process. [14] [15] [16] [17] The RapidPlan module in Eclipse treatment planning system of version 13.5 or later (Varian Medical Systems, Palo Alto, CA) has commercialized the knowledge-based solution 18, 19 and displayed good compatibility across patient orientations, treatment techniques, and systems. 20, 21 Well-trained RapidPlan models have outperformed conventional trial and error-based manual planning by reducing excess organs-atrisk (OAR) dose with greater consistency. 17, 20, [22] [23] [24] [25] [26] [27] [28] [29] [30] Should the model performance be highly dependent on the library volume 31 and average quality of the training plans, 17, 32 incorporating the modelimproved constituent training plans into the model (closed-loop) 25 may potentially evolve the model as a cycle of interactive improvement. There has been attempts to iteratively improve KDE (kernel density estimation)-based DVH prediction model. However, compared with RapidPlan, the KDE algorithm did not consider division between in-field and out-of-field regions, and the generated point objectives were tested on limited sample size based on Pinnacle (Philips Radiation Oncology Systems, Fitchburg, WI), 33 whose optimization algorithm, progressive optimization algorithm (POA) is different from Eclipse's Photon Optimizer (PO). This study aims to evaluate the performance of the closed-loop model evolution on rectal cancer patients in the environment of Eclipse RapidPlan V13.6
knowledge-based treatment planning system.
| MATERIALS AND METHODS
As a summary, Fig. 1 displays a schematic workflow explaining the evolution process and naming abbreviations.
2.A | Initial model configuration
The planning and modeling details can be found in our previous publications. 17, 20, 34 In summary, 81 clinical VMAT plans (P c ) for preoperative rectal cancer patients were refined manually by experts (besteffort manual plans, P 0 ) to guarantee the initial plan quality and push a stricter evaluation criteria on the closed-loop method. Plans were optimized to deliver 50.6 Gy and 41.8 Gy to 95% PTV boost and 95%
PTV respectively in 22 fractions. 35 The extracted structure sets, prescriptions, and field geometries of P 0 were regressed as the initial DVH estimation model (M 0 ) and statistically verified using Varian Model Analytics tool. 36 Model-generated optimization objectives and priorities were assisted by additional manual constraints to make the model comply with our clinical protocols. The validations on 100+ patients have demonstrated that M 0 -generated personalized objectives improved plan quality and consistency significantly compared to the clinical plans.
17,20
2.B | Model evolution
As shown in Fig. 1 
2.D | Statistical methods
Using SPSS (v21.0, IBM Analytics, Armonk, NY), normality was tested using Shapiro-Wilk method. Normal and abnormal data were analyzed by paired samples t-test and Wilcoxon signed-rank test respectively (two-tailed, significant level 0.05).
| RESULTS

3.A | Closed-loop reoptimizations
After replacing the training library with 75 P 1+ during the first
closed-loop refinement, the 81 plans used to configure model M 1
were of comparable HI and CI (mean difference < 0.03) relative to the library of M 0 , but of consistently lower mean dose to all OARs. respectively (all P < 0.01), relative to M 0 library.
After updating the library of model M 2 with 23 P 2+ that were superior to both P 0 and P 1 forms after the second closed-loop reoptimization, the changes of HI and CI were negligible (mean difference < 0.03), yet the D mean_FH , D mean_UB , and D mean_SB of 81 plans were further significantly reduced by 0.04 Gy (0.28%), 0.18 Gy (0.77%), 0.22 Gy (1.01%) on average respectively (all P < 0.01), relative to M 1 library.
More details are shown in Tables 1 and 2 .
3.B | Validations
Based on 30 VMAT validation cases, knowledge-based reoptimizations using various models yielded comparable target coverage (mean difference of HI and CI < 0.01), but the impact on the OARs were more complex and intertwined: relative to the results of using M 0 , monotonically increased magnitudes of mean dose reduction to two OARs were observed using the refined models T 
T A B L E 4
The open-loop validation results of various models on 30 additional patients: organs-at-risk.
Femoral head The largely overlapping target DVHs in Fig. 2 echoed the comparable target numeric in Table 3 
